Antibody-drug Conjugate Information

General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0PTOUF
ADC Name
LY-4101174
Synonyms
LY-4101174; LY 4101174; LY4101174
   Click to Show/Hide
Organization
Eli Lilly & Co.
Drug Status
Phase 1
Indication
In total 11 Indication(s)
Breast cancer
Phase 1
Clinical Trial
Cervical cancer
Phase 1
Clinical Trial
Head and neck cancer
Phase 1
Clinical Trial
Kidney cancer
Phase 1
Clinical Trial
Lung cancer
Phase 1
Clinical Trial
Oesophageal cancer
Phase 1
Clinical Trial
Ovarian cancer
Phase 1
Clinical Trial
Pancreatic cancer
Phase 1
Clinical Trial
Prostate cancer
Phase 1
Clinical Trial
Solid tumor
Phase 1
Clinical Trial
Urothelial cancer
Phase 1
Clinical Trial
Drug-to-Antibody Ratio
8
Antibody Name
Undisclosed
Antigen Name
Nectin-4 (NECTIN4)
  Antigen Info 
Payload Name
Monomethyl auristatin E
  Payload Info 
Therapeutic Target
Microtubule (MT)
  Target Info 
Conjugate Type
Random Cysteines